Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
BLIN - Bridgeline Digital Inc - Stock Price Chart
TickerBLIN [NASD]
CompanyBridgeline Digital Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap12.40MEPS (ttm)-0.96
P/E-EPS this Y-233.33%
Forward P/E-EPS next Y25.00%
PEG-EPS past 5Y60.05%
P/S0.80EPS next 5Y-
P/B1.13EPS Q/Q-655.70%
Dividend-Sales Q/Q-8.03%
Insider Own17.69%Inst Own7.87%
Insider Trans0.00%Inst Trans-15.50%
Short Float1.07%EarningsFeb 14/a
Analyst Recom1.00Target Price1.65
Avg Volume66.65K52W Range0.70 - 1.43
Apr-25-24 08:30AM Leading Office Furniture Manufacturer Implements Bridgeline's HawkSearch (GlobeNewswire)
Apr-23-24 08:30AM Springthrough Partners with Bridgeline to Power Search (GlobeNewswire)
Apr-18-24 08:30AM Bridgeline to Showcase AI-Powered Search at B2B Online Chicago (GlobeNewswire)
Apr-17-24 08:30AM Bridgeline's CEO, Ari Kahn, Named Top 20 Visionary CEO of 2024 (GlobeNewswire)
Apr-11-24 08:30AM Bridgeline Announces Successful Completion of SOC 2 Type II Audit (GlobeNewswire)
Apr-09-24 08:30AM Schaedler Yesco Distribution Launches Bridgeline's HawkSearch Implementation (GlobeNewswire)
Apr-04-24 08:30AM Global Technology Leader Implements Bridgeline's AI-Powered HawkSearch (GlobeNewswire)
Apr-03-24 08:30AM Independent Publisher Implements Bridgeline's HawkSearch (GlobeNewswire) +9.91%
Mar-29-24 08:50AM Bridgeline Digital (BLIN) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Mar-28-24 08:30AM Bridgeline Releases Zeus Update with Concept and Image Search (GlobeNewswire)
HLP - Hongli Group Inc - Stock Price Chart
TickerHLP [NASD]
CompanyHongli Group Inc
CountryChina
IndustrySteel
Market Cap21.89MEPS (ttm)0.16
P/E11.08EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.17EPS next 5Y-
P/B1.06EPS Q/Q-53.88%
Dividend-Sales Q/Q-14.98%
Insider Own60.76%Inst Own0.34%
Insider Trans0.00%Inst Trans-
Short Float2.15%Earnings-
Analyst Recom-Target Price-
Avg Volume232.17K52W Range0.72 - 8.68
Jun-29-23 08:27AM Boasting A 22% Return On Equity, Is Hongli Group Inc. (NASDAQ:HLP) A Top Quality Stock? (Simply Wall St.)
May-02-23 04:30PM Hongli Group Inc. Announces the Exercise of the Underwriters Over-Allotment Option (GlobeNewswire) -24.27%
Mar-31-23 04:10PM Hongli Group Inc. Announces Closing of US$8.25 Million Initial Public Offering (GlobeNewswire)
Mar-29-23 08:56AM Hongli Group Inc. Announces Pricing of Initial Public Offering (GlobeNewswire)
GVP - GSE Systems, Inc. - Stock Price Chart
TickerGVP [NASD]
CompanyGSE Systems, Inc.
CountryUSA
IndustrySoftware - Application
Market Cap7.91MEPS (ttm)-3.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-81.20%
P/S0.18EPS next 5Y-
P/B1.39EPS Q/Q-19.86%
Dividend-Sales Q/Q-5.56%
Insider Own22.88%Inst Own10.89%
Insider Trans0.00%Inst Trans6.01%
Short Float1.97%EarningsApr 01/a
Analyst Recom1.00Target Price13.00
Avg Volume50.51K52W Range1.21 - 7.10
Apr-16-24 09:00AM GSE Solutions Awarded $765K Contract for Nuclear Engineering Services for a 24-month Fuel Cycle Operation (PR Newswire) -10.00%
Apr-03-24 09:24AM GSE Systems, Inc. (NASDAQ:GVP) Q4 2023 Earnings Call Transcript (Insider Monkey) +13.86%
Apr-02-24 06:29AM Q4 2023 GSE Systems Inc Earnings Call (Thomson Reuters StreetEvents) +13.62%
Apr-01-24 08:53PM GVP Stock Earnings: GSE Systems Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:05PM GSE Systems Reports Fourth Quarter and Fiscal 2023 Financial Results (PR Newswire)
Mar-25-24 04:05PM GSE Solutions Schedules Release of Fourth Quarter and Fiscal 2023 Financial Results and Conference Call (PR Newswire)
Nov-15-23 01:34PM GSE Systems, Inc. (NASDAQ:GVP) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.41%
Nov-14-23 04:05PM GSE Systems Reports Third Quarter 2023 Financial Results (PR Newswire) +9.12%
Nov-09-23 09:00AM Southeast Texas Nuclear Power Supplier Selects GSE Solutions as a Preferred Engineering Services Provider (PR Newswire) -10.40%
Nov-08-23 04:15PM GSE Solutions Schedules Release of Third Quarter Fiscal 2023 Financial Results and Conference Call (PR Newswire)
RVSB - Riverview Bancorp, Inc. - Stock Price Chart
TickerRVSB [NASD]
CompanyRiverview Bancorp, Inc.
CountryUSA
IndustryBanks - Regional
Market Cap79.16MEPS (ttm)0.18
P/E20.91EPS this Y-30.56%
Forward P/E8.33EPS next Y80.00%
PEG1.74EPS past 5Y-25.09%
P/S1.19EPS next 5Y12.00%
P/B0.51EPS Q/Q-200.86%
Dividend6.40%Sales Q/Q-12.58%
Insider Own7.44%Inst Own64.72%
Insider Trans1.71%Inst Trans-1.98%
Short Float0.20%EarningsApr 25/a
Analyst Recom2.00Target Price6.00
Avg Volume21.55K52W Range4.12 - 6.57
Apr-25-24 09:54PM RVSB Stock Earnings: Riverview Bancorp Beats EPS, Misses Revenue for Q4 2024 (InvestorPlace)
05:02PM Riverview Bancorp: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:25PM Riverview Bancorp Reports Fourth Fiscal Quarter 2024 and Fiscal Year 2024 Financial Results; Announces Balance Sheet Restructuring (GlobeNewswire)
Apr-01-24 09:00AM Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share (GlobeNewswire)
Jan-25-24 05:20PM Riverview Bancorp (RVSB) Q3 Earnings and Revenues Miss Estimates (Zacks)
04:18PM Riverview Bancorp: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:04PM Riverview Bancorp Earns $1.5 Million in Third Fiscal Quarter 2024 (GlobeNewswire)
Dec-26-23 04:00PM Riverview Bancorp Declares Quarterly Cash Dividend of $0.06 Per Share (GlobeNewswire)
Oct-26-23 05:15PM Riverview Bancorp (RVSB) Meets Q2 Earnings Estimates (Zacks)
04:17PM Riverview Bancorp: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
CETY - Clean Energy Technologies Inc - Stock Price Chart
TickerCETY [NASD]
CompanyClean Energy Technologies Inc
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap63.58MEPS (ttm)-0.15
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y6.24%
P/S4.21EPS next 5Y-
P/B11.42EPS Q/Q-298.50%
Dividend-Sales Q/Q3468.80%
Insider Own70.84%Inst Own0.43%
Insider Trans0.00%Inst Trans-
Short Float1.06%EarningsNov 28/b
Analyst Recom-Target Price-
Avg Volume803.19K52W Range0.45 - 3.12
Apr-18-24 09:29AM Clean Energy Technologies Signs MOU with International Private Equity Fund (GlobeNewswire)
Mar-27-24 05:20PM 12 Most Undervalued Renewable Energy Stocks To Buy According To Analysts (Insider Monkey)
Feb-07-24 08:30AM Clean Energy Technologies Affiliate Announces Favorable Order from Maine Public Utilities Commission (GlobeNewswire) -21.32%
Jan-25-24 08:30AM Clean Energy Technologies Continues Normal Operations Among Stock Volatility (GlobeNewswire) +7.97%
Nov-28-23 08:30AM Clean Energy Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-21-23 08:30AM Clean Energy Technologies, Inc. Leads Discussions on Sustainable Energy at APEC 2023 (GlobeNewswire) -6.98%
Nov-20-23 09:49AM Clean Energy Technologies, Inc. Announces Significant Balance Sheet Improvement due to Financial Restructuring (GlobeNewswire)
Nov-15-23 05:29PM Clean Energy Technologies, Inc. Announces Conversion of $1.95 Million Notes Payable to Equity (GlobeNewswire)
Oct-12-23 08:45AM CETY with RPG Energy Group to Implement Advanced Waste Heat to Power Generation Solution at Stanley Black & Decker Facility in Tennessee (GlobeNewswire)
Sep-08-23 02:00PM Clean Energy Technologies to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13 (GlobeNewswire)
ATXI - Avenue Therapeutics Inc - Stock Price Chart
TickerATXI [NASD]
CompanyAvenue Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.66MEPS (ttm)4.87
P/E0.93EPS this Y58.16%
Forward P/E-EPS next Y9.76%
PEG-EPS past 5Y50.07%
P/S-EPS next 5Y-
P/B0.97EPS Q/Q358.44%
Dividend-Sales Q/Q-
Insider Own11.82%Inst Own-
Insider Trans-89.85%Inst Trans-
Short Float0.01%EarningsMar 18/a
Analyst Recom1.00Target Price56.25
Avg Volume27.54K52W Range5.78 - 93.75
Apr-29-24 08:00AM Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds (GlobeNewswire) -27.18%
Apr-24-24 07:30AM Avenue Therapeutics Announces Reverse Stock Split (GlobeNewswire) -29.63%
Mar-25-24 08:30AM Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024 (GlobeNewswire)
Mar-19-24 06:53AM ATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023 (InvestorPlace)
Mar-18-24 04:05PM Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights (GlobeNewswire)
Mar-15-24 08:15AM Avenue Therapeutics Receives Positive Listing Determination from Nasdaq (GlobeNewswire)
Mar-11-24 08:00AM Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting (GlobeNewswire) -15.62%
Feb-22-24 08:30AM Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy (GlobeNewswire)
Jan-16-24 08:40AM Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE) -11.03%
Jan-11-24 08:00AM Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference (GlobeNewswire)
ELDN - Eledon Pharmaceuticals Inc - Stock Price Chart
TickerELDN [NASD]
CompanyEledon Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap57.35MEPS (ttm)-1.90
P/E-EPS this Y12.83%
Forward P/E-EPS next Y45.44%
PEG-EPS past 5Y43.37%
P/S-EPS next 5Y-
P/B0.69EPS Q/Q90.62%
Dividend-Sales Q/Q-
Insider Own5.59%Inst Own38.19%
Insider Trans0.00%Inst Trans-2.05%
Short Float0.14%EarningsMar 28/a
Analyst Recom1.00Target Price15.60
Avg Volume88.55K52W Range1.07 - 2.95
Mar-28-24 04:01PM Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results (GlobeNewswire)
Mar-25-24 04:56PM Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection (GlobeNewswire)
Mar-21-24 10:31AM Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human (GlobeNewswire) +11.24%
Feb-13-24 07:01PM Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-04-24 04:40PM Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook (GlobeNewswire)
Dec-04-23 06:00PM Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +16.67%
Nov-29-23 04:05PM Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference (GlobeNewswire) -6.67%
Nov-09-23 04:01PM Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results (GlobeNewswire)
Nov-08-23 04:05PM Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference (GlobeNewswire)
Nov-02-23 09:05AM Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation (GlobeNewswire) -10.37%
CGC - Canopy Growth Corporation - Stock Price Chart
TickerCGC [NASD]
CompanyCanopy Growth Corporation
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap758.04MEPS (ttm)-16.06
P/E-EPS this Y90.96%
Forward P/E-EPS next Y83.42%
PEG-EPS past 5Y-76.81%
P/S3.09EPS next 5Y13.28%
P/B1.67EPS Q/Q51.57%
Dividend-Sales Q/Q-22.69%
Insider Own28.90%Inst Own6.91%
Insider Trans-0.39%Inst Trans-
Short Float13.90%EarningsFeb 09/b
Analyst Recom3.54Target Price4.89
Avg Volume11.87M52W Range2.76 - 19.20
Apr-22-24 09:30AM Cannabis Market Flourishes Amid Global Legalization, Driving Concerns About Road Safety (GlobeNewswire)
Apr-18-24 04:30PM Canopy Growth Announces CBI Conversion to Exchangeable Shares and Newly Constituted Board of Directors (PR Newswire) +20.65%
02:59PM Is a Short Squeeze Brewing in Canopy Growth (CGC) Stock? (InvestorPlace)
Apr-15-24 01:45PM CGC Stock Alert: Canopy Growth Gets Green Light for Canopy USA (InvestorPlace) -10.51%
07:30AM CANOPY GROWTH ANNOUNCES RESULTS OF SPECIAL MEETING OF SHAREHOLDERS (PR Newswire)
05:00AM Navigating the Growing Cannabis Stock Landscape in 2024 (News Direct)
Apr-12-24 03:03PM CGC Stock Is on Watch Amid Canopy USA' Vote (InvestorPlace)
Apr-09-24 07:42AM Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -9.58%
Apr-08-24 03:08PM CGC Stock: What to Know Ahead of Canopy Growth's Share Conversion Vote This Week (InvestorPlace)
Apr-04-24 10:59AM The 5 Biggest Buyers of Canopy Growth (CGC) Stock (InvestorPlace) -10.19%
RLMD - Relmada Therapeutics Inc - Stock Price Chart
TickerRLMD [NASD]
CompanyRelmada Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap106.50MEPS (ttm)-3.28
P/E-EPS this Y6.83%
Forward P/E-EPS next Y29.32%
PEG-EPS past 5Y-2.94%
P/S-EPS next 5Y-
P/B1.24EPS Q/Q33.67%
Dividend-Sales Q/Q-
Insider Own15.86%Inst Own52.34%
Insider Trans3.72%Inst Trans4.25%
Short Float6.73%EarningsMar 19/a
Analyst Recom2.20Target Price10.88
Avg Volume213.38K52W Range2.36 - 7.22
Mar-20-24 10:27AM Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript (Insider Monkey) -17.41%
06:27AM Q4 2023 Relmada Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-19-24 08:52PM RLMD Stock Earnings: Relmada Therapeutics Misses EPS for Q4 2023 (InvestorPlace)
05:31PM Relmada Therapeutics Inc Reports Full-Year and Q4 2023 Financial Results (GuruFocus.com)
04:15PM Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results (PR Newswire)
Mar-12-24 07:30AM Relmada Therapeutics to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call and Webcast on March 19, 2024 (PR Newswire)
Mar-05-24 07:30AM Relmada Therapeutics to Participate in the Leerink Partners Global Biopharma Conference (PR Newswire)
Feb-01-24 03:02PM Relmada Therapeutics Inc CEO Sergio Traversa Acquires 100,000 Shares (GuruFocus.com) +16.03%
Jan-05-24 05:12PM Health Care Roundup: Market Talk (The Wall Street Journal) +7.27%
Jan-04-24 07:30AM Relmada Therapeutics Provides Corporate Update (PR Newswire) -31.68%
ITRM - Iterum Therapeutics Plc - Stock Price Chart
TickerITRM [NASD]
CompanyIterum Therapeutics Plc
CountryIreland
IndustryBiotechnology
Market Cap25.30MEPS (ttm)-2.96
P/E-EPS this Y30.47%
Forward P/E-EPS next Y56.38%
PEG-EPS past 5Y19.62%
P/S-EPS next 5Y-
P/B-EPS Q/Q-126.55%
Dividend-Sales Q/Q-
Insider Own2.52%Inst Own6.94%
Insider Trans18.62%Inst Trans-12.14%
Short Float7.48%EarningsMar 28/b
Analyst Recom1.00Target Price6.50
Avg Volume615.91K52W Range0.62 - 2.50
Apr-29-24 08:00AM Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem (GlobeNewswire) -7.78%
Apr-02-24 10:22AM Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-29-24 12:09AM Q4 2023 Iterum Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 11:53AM ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023 (InvestorPlace)
07:00AM Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-21-24 04:30PM Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 (GlobeNewswire)
Mar-15-24 08:00AM Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat (GlobeNewswire)
Mar-07-24 07:57AM Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up (Zacks)
Mar-06-24 08:00AM Iterum Therapeutics Provides Business Update (GlobeNewswire) +17.79%
Feb-01-24 03:03PM Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC (GuruFocus.com)
1⋯56789101112131415⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.